Curcuminoid analogs with potent activity against <i>Trypanosoma</i> and <i>Leishmania</i> species

The natural curcuminoids curcumin (1), demethoxycurcumin (2) and bisdemethoxycurcumin (3) have been chemically modified to give 46 analogs and 8 pairs of 1:1 mixture of curcuminoid analogs and these parent curcuminoids and their analogs were assessed against protozoa of the Trypanosoma and Leishmania species. The parent curcuminoids exhibited low antitrypanosomal activity (EC50 for our drug-sensitive Trypanosoma brucei brucei line (WT) of compounds 1, 2 and 3 are 2.5, 4.6 and 7.7á[mu]M, respectively). Among 43 curcuminoid analogs and 8 pairs of 1:1 mixture of curcuminoid analogs tested, 8 pure analogs and 5 isomeric mixtures of analogs exhibited high antitrypanosomal activity in submicromolar order of magnitude. Among these highly active analogs, 1,7-bis(4-hydroxy-3-methoxyphenyl)hept-4-en-3-one (40) was the most active compound, with an EC50 value of 0.053á¦á0.007á[mu]M; it was about 2-fold more active than the standard veterinary drug diminazene aceturate (EC50 0.12á¦á0.01á[mu]M). Using a previously characterized diminazene-resistant T. b. brucei (TbAT1-KO) and a derived multi-drug resistant line (B48), no cross-resistance of curcuminoids was observed to the diamidine and melaminophenyl arsenical drugs that are the current treatments. Indeed, curcuminoids carrying a conjugated keto (enone) motif, including 40, were significantly more active against T. b. brucei B48. This enone motif was found to contribute to particularly high trypanocidal activity against all Trypanosoma species and strains tested. The parent curcuminoids showed low antileishmanial activity (EC50 values of compounds 1 and 2 for Leishmania mexicana amastigotes are 16á¦á3 and 37á¦á6á[mu]M, respectively) while the control drug, pentamidine, displayed an EC50 of 16á¦á2á[mu]M. Among the active curcuminoid analogs, four compounds exhibited EC50 values of less than 5á[mu]M against Leishmania major promastigotes and four against L. mexicana amastigotes. No significant difference in sensitivity to curcuminoids between L. major promastigotes and L. mexicana amastigotes was observed. The parent curcuminoids and most of their analogs were also tested for their toxicity against human embryonic kidney (HEK) cells. All the curcuminoids exhibited lower toxicity to HEK cells than to T. b. brucei bloodstream forms and only one of the tested compounds showed significantly higher activity against HEK cells than curcumin (1). The selectivity index for T. b. brucei ranged from 3-fold to 1500-fold. The selectivity index for the most active analog, the enone 40, was 453-fold

Stereochemical evaluation of sesquiterpene quinones from two sponges of the genus Dactylospongia and the implication for enantioselective processes in marine terpene biosynthesis

Silver nitrate flash chromatography of the organic extract from the sponge Dactylospongia elegans has led to the isolation of three new sesquiterpene quinones isohyatellaquinone (7), 7,8-dehydrocyclospongiaquinone-2 (8) and 9-epi-7,8-dehydrocyclospongiaquinone-2 (9) together with the known quinones dictyoceratidaquinone (6), mamanuthaquinone (10), ilimaquinone (11), hyatellaquinone (12) and the sesterterpene furospinosulin (22). The relative stereochemistry of dictyoceratidaquinone (6) is assigned on the basis of NOESY analysis. A second species of Dactylospongia, thought to be new to science, was found to contain ent-(7) together with the new quinone neomamanuthaquinone (13). The isolation of antipodal sesquiterpenes from closely related species has implications for the stereochemical evaluation of terpene metabolites. The biosynthetic processes in these marine sponges may involve terpene synthases that do not discriminate chiral substrates or may result from the presence of multiple terpene synthases, each with differing enantioselectivity

A reduced curcuminoid analog as a novel inducer of fetal hemoglobin

Thalassemia is an inherited disorder of hemoglobin molecules that is characterized by an imbalance of α- and β-globin chain synthesis. Accumulation of unbound α-globin chains in erythroid cells is the major cause of pathology in β-thalassemia. Stimulation of γ-globin production can ameliorate disease severity as it combines with the α-globin to form fetal hemoglobin. We examined γ-globin-inducing effect of curcuminoids extracted from Curcuma longa L. and their metabolite reduced forms in erythroid leukemia K562 and human primary erythroid precursor cells. The results showed that curcuminoid compounds, especially bisdemethoxycurcumin are potential γ-globin enhancers. We also demonstrated that its reduced analog, hexahydrobisdemethoxycurcumin (HHBDMC), is most effective and leads to induction of γ-globin mRNA and HbF in primary erythroid precursor cells for 3.6 ± 0.4- and 2.0 ± 0.4-folds, respectively. This suggested that HHBDMC is the potential agent to be developed as a new therapeutic drug for β-thalassemia and related β-hemoglobinopathies